Joseph Marks's most recent trade in Augmedix Inc was a trade of 52,632 Common Stock done . Disclosure was reported to the exchange on June 16, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Augmedix Inc | Joseph Marks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 52,632 | 52,632 | - | - | Common Stock | |
| Augmedix Inc | Joseph Marks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 52,632 | 0 | - | - | Restricted Stock Units | |
| Augmedix Inc | Joseph Marks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 52,632 | 52,632 | - | - | Restricted Stock Units |